TY - EJOU
AU - Qi, Muyu
AU - Lan, Xiaoping
AU - Li, Jia
AU - Ge, Junwen
AU - Shen, Li
AU - Zhang, Rufang
TI - Whole Exome Sequencing Identifies A Novel Pathogenic Bmpr2 Variant in Pulmonary Atresia
T2 - Structural and Congenital Heart Disease
PY - 2021
VL - 16
IS - 5
SN - 3071-1738
AB - Objective: Pulmonary atresia (PA) is a rare type of complex cyanotic congenital heart defect characterized primarily by an undeveloped pulmonary valve or pulmonary artery. Therefore, defining a disease-causing gene
mutation in a pulmonary atresia family is a possible method of genetic counseling, future prenatal diagnosis,
and therapeutic approaches for pulmonary atresia. Methods: Blood samples were collected from six PA family
members, and genomic DNA was extracted using the QIAamp DNA Blood Mini Kit. Gene detection was performed using a second-generation sequencing gene panel. Results: Genetic testing results indicated that a heterozygous mutation originating from maternal inheritance was detected in the BMPR2 gene of the proband’s
genomic DNA. The pathogenic gene was c.2804C>T (p. A935V). The mutation was also detected in the genomic
DNA of the proband’s elder brother (III-1), but not in other family members. Conclusion: To the best of our
knowledge, this is the first study to report the BMPR2 variant responsible for pulmonary atresia. The frequency
of the c.2804C>T (p. A935V) mutation detected in this family is extremely low in the normal population (1/
246048). The mutation was highly conserved among different species. Sorting intolerant from tolerant (SIFT) predicts it to be a harmful mutation.
KW - Pulmonary atresia; gene mutation; BMPR2 gene
DO - 10.32604/CHD.2021.015887